Publication date: October 2023
Source: Leukemia Research, Volume 133
Author(s): Mrinal M. Patnaik
Corrigendum to “Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities” [Leuk. Res. 130 (2023) 1–7]
Publication date: October 2023
Source: Leukemia Research, Volume 133
Author(s): Ismail Elbaz Younes, Lee Syler, Amira Hamed
The shifting therapeutic paradigm for relapsed/refractory mantle cell lymphoma
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Sumukh Arun Kumar, Jenny Gao, Shyam A. Patel
AML with <em>CEBPA</em> mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Davidson Zhao, Qianghua Zhou, Mojgan Zarif, Entsar Eladl, Cuihong Wei, Eshetu G. Atenafu, Andre Schuh, Anne Tierens, Yu Wing Tony Yeung, Mark D. Minden, Hong Chang
MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Gunnar Larfors, Daniel Moreno Berggren, Hege Garelius, Lars Nilsson, Bengt Rasmussen, Eva Hellström-Lindberg, Elisabeth Ejerblad
Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Swe Mar Linn, Igor Novitzky-Basso, Christopher Patriquin, Ivan Pasic, Wilson Lam, Arjun Law, Fotios V. Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey Lipton, Rajat Kumar, Jonas Mattsson, David Barth, Dennis Dong Hwan Kim
Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulations
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Shyam A. Patel, Elisa Bello, Andrew Wilks, Jonathan M. Gerber, Narayanan Sadagopan, Jan Cerny
The chaperone protein GRP78 released from MPN cells increases the expression of lysyl oxidase in a human stromal cell line
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Kei Nakajima, Megumi Suzuki, Ichiro Kawashima, Megumi Koshiisi, Takuma Kumagai, Takeo Yamamoto, Masaru Tanaka, Keita Kirito
Deep immunophenotypic analysis of the bone marrow progenitor cells in myelodysplastic syndromes
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Afshin Shameli, Poonam Dharmani-Khan, Iwona Auer, Meer-Taher Shabani-Rad
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Tamanna Haque, Felix López Cadenas, Blanca Xicoy, Ana Alfonso-Pierola, Uwe Platzbecker, Irit Avivi, Andrew M. Brunner, Jöerg Chromik, Daniel Morillo, Manish R. Patel, Jose Falantes, Heather A. Leitch, Ulrich Germing, Meir Preis, Laurie Lenox, Josh Lauring, Regina J. Brown, Anna Kalota, Jaydeep Mehta, Friederike Pastore